Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP242855.RAcwbgLgijKvuyF8HRnEKA4F5yJcus7iYa1uO22qbqf2M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP242855.RAcwbgLgijKvuyF8HRnEKA4F5yJcus7iYa1uO22qbqf2M130_assertion type Assertion NP242855.RAcwbgLgijKvuyF8HRnEKA4F5yJcus7iYa1uO22qbqf2M130_head.
- NP242855.RAcwbgLgijKvuyF8HRnEKA4F5yJcus7iYa1uO22qbqf2M130_assertion description "[Within 17q, the genes topoisomerase II-alpha (TOP2A), ets variant gene 4 (E1A enhancer binding protein, E1AF) (ETV4) and baculoviral IAP repeat-containing 5 (survivin) (BIRC5) showed increased expression in all samples compared to two benign tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP242855.RAcwbgLgijKvuyF8HRnEKA4F5yJcus7iYa1uO22qbqf2M130_provenance.
- NP242855.RAcwbgLgijKvuyF8HRnEKA4F5yJcus7iYa1uO22qbqf2M130_assertion evidence source_evidence_literature NP242855.RAcwbgLgijKvuyF8HRnEKA4F5yJcus7iYa1uO22qbqf2M130_provenance.
- NP242855.RAcwbgLgijKvuyF8HRnEKA4F5yJcus7iYa1uO22qbqf2M130_assertion SIO_000772 18522746 NP242855.RAcwbgLgijKvuyF8HRnEKA4F5yJcus7iYa1uO22qbqf2M130_provenance.
- NP242855.RAcwbgLgijKvuyF8HRnEKA4F5yJcus7iYa1uO22qbqf2M130_assertion wasDerivedFrom befree-20150227 NP242855.RAcwbgLgijKvuyF8HRnEKA4F5yJcus7iYa1uO22qbqf2M130_provenance.
- NP242855.RAcwbgLgijKvuyF8HRnEKA4F5yJcus7iYa1uO22qbqf2M130_assertion wasGeneratedBy ECO_0000203 NP242855.RAcwbgLgijKvuyF8HRnEKA4F5yJcus7iYa1uO22qbqf2M130_provenance.